Medipal Holdings ( (JP:7459) ) has provided an update.
Medipal Holdings Corporation reported a notable financial performance for the third quarter of the fiscal year ending March 31, 2025, with net sales reaching ¥2,807,172 million, marking a 3.4% increase from the previous year. The company’s operating profit surged by 21.9%, driven by strategic consolidations including the integration of PreMedica Inc., FloraDiscovery Inc., and PRESUSCUBE Corporation, enhancing its market positioning and operational scope.
More about Medipal Holdings
Medipal Holdings Corporation is a company listed on the Tokyo Stock Exchange, primarily operating in the healthcare and pharmaceutical distribution industry. The company focuses on the distribution of pharmaceuticals, cosmetics, and other health-related products, serving a crucial role in the supply chain of medical and wellness goods in Japan.
YTD Price Performance: -4.82%
Average Trading Volume: 761
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.67B
For a thorough assessment of 7459 stock, go to TipRanks’ Stock Analysis page.